ArticleBMC oral health2026
Naringenin ameliorates swine pulpitis by modulating immune response.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundPreserving dental pulp vitality is crucial for maintaining the physiological function of the tooth. Naringenin (Nar), known for its immunomodulatory properties, has shown pharmacological effects on various inflammatory diseases. This study aimed to investigate the therapeutic potential of Nar in treating Porphyromonas gingivalis lipopolysaccharide (P.g-LPS)-induced pulpitis in a swine model and to elucidate the mechanisms underlying its therapeutic efficacy.
methodsSwine premolars with P.g-LPS-induced pulpitis were divided into four groups: sham, hydrogel, iRoot BP PLUS, and Nar hydrogel. Treatment outcomes were evaluated by assessing neutrophil infiltration, dentin-like tissue regeneration, and coronal pulp tissue preservation using histological and immunohistochemical techniques. To further examine potential cellular responses, the effects of Nar were studied in human dental pulp fibroblasts (hDPFs), human peripheral blood-derived neutrophils (hNeu.), and differentiated HL-60 cells (dHL-60). Surface markers were analyzed using fluorescence-activated cell sorting (FACS), cytokine levels were measured by ELISA, and mineralization was assessed using alkaline phosphatase and Alizarin Red S staining. Neutrophil phagocytosis, bactericidal activity, intracellular reactive oxygen species (ROS) levels, and translocation of transcription factor EB (TFEB)-mediated lysosomal activity were evaluated. Statistical analyses included Shapiro-Wilk test and one-way ANOVA or Kruskal-Wallis test with appropriate post hoc comparisons.
resultsThe sham group showed severe pulp tissue necrosis and an intense inflammatory response. Hydrogel alone exhibited limited therapeutic effects. Both Nar hydrogel and iRoot BP PLUS promoted dentin-like tissue formation; however, Nar hydrogel reduced inflammatory infiltration and preserved a greater proportion of coronal pulp tissue. In vitro, Nar reduced inflammatory cytokine secretion from hDPFs and neutrophils and improved P.g-LPS-impaired mineralization capacity in hDPFs. Nar also enhanced the phagocytic and bactericidal activities of dHL-60 cells, accompanied by controlled ROS elevation and increased TFEB-mediated lysosomal activity.
conclusionsNar demonstrates therapeutic potential for pulpitis management by modulating inflammation and promoting dentin-like tissue regeneration. Its efficacy likely stems from the fine-tuning of inflammatory responses. These findings suggest that Nar may represent a potential biological alternative to conventional pulp capping materials for vital pulp therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.